US-CRIME-JUSTICE-SHKRELI
US Attorney Robert Capers speaks during press conference in New York on December 17, 2015, to announce the unsealing of an indictment charging Martin Shkreli, a former hedge fund manager and Chief Executive Officer of Retrophin. Shkreli, the pharmaceutical CEO who caused a storm in September by jacking up the price of a life-saving drug, was arrested Thursday on fraud charges, prosecutors said. His arrest was not linked to the 5,000-percent increase in the price of Daraprim, a drug used to treat malaria and infections suffered by HIV-positive individuals. The FBI said he was targeted instead in an $11 million embezzlement probe at another company he once led, Retrophin. AFP PHOTO/JEWEL SAMAD / AFP / JEWEL SAMAD (Photo credit should read JEWEL SAMAD/AFP via Getty Images)
PURCHASE A LICENCE
How can I use this image?
₹23,000.00
INR
DETAILS
Restrictions:
Contact your local office for all commercial or promotional uses. Full editorial rights UK, US, Ireland, Italy, Spain, Canada (not Quebec). Restricted editorial rights elsewhere, please call local office.
Credit:
Editorial #:
501757704
Collection:
AFP
Date created:
17 December, 2015
Upload date:
Licence type:
Release info:
Not released. More information
Source:
AFP
Barcode:
AFP
Object name:
Was8990012
Max file size:
4896 x 3264 px (41.45 x 27.64 cm) - 300 dpi - 6 MB